1921
Volume 82, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

A predictive marker for the success treatment of canine leishmaniasis is required for the application of a more rational therapy protocol, which must improve the probability of cure and reduce resistance to drugs. We investigated the dynamics and predictive value of antibodies against insect-derived recombinant proteins rKMPII and rTRYP by using an enzyme-linked immunosorbent assay with retrospective serum samples from 36 dogs during treatment of canine leishmaniasis. In the entire group of dogs, concentrations of antibodies against rKMPII and rTRYP significantly decreased earlier than concentrations of antibodies against crude total antigen (one versus six months), which suggested that the dynamics of antibodies against recombinant proteins may be useful for assessing clinical improvement after treatment. Interestingly, decreases in antibody concentrations against rKMPII occurred earlier in disease-free dogs than in dogs that remain clinically ill one year after beginning of treatment, which suggested that these antibodies may be useful for predicting disease-free survival one year after the beginning of therapy against canine leishmaniasis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.09-0147
2010-05-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/82/5/795.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0147&mimeType=html&fmt=ahah

References

  1. Berrahal F, Mary C, Roze M, Berenger A, Escoffier K, Lamouroux D, Dunan S, , 1996. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am J Trop Med Hyg 55: 273277.
  2. Solano-Gallego L, Morell P, Arboix M, Alberola J, Ferrer L, , 2001. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J Clin Microbiol 39: 560563.[Crossref]
  3. da Silva VO, Borja-Cabrera GP, Correia Pontes NN, de Souza EP, Luz KG, Palatnik M, Palatnik de Sousa CB, , 2000. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 19: 10821092.[Crossref]
  4. Gavgani AS, Hodjati MH, Mohite H, Davies CR, , 2002. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 360: 374379.[Crossref]
  5. Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, Mayrink W, Guerra LL, Andrade RA, Correa-Oliveira R, Martins-Filho OA, , 2006. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi . Vet Immunol Immunopathol 112: 102116.[Crossref]
  6. Rodriguez-Cortes A, Fernandez-Bellon H, Ramis A, Ferrer L, Alberola J, Solano-Gallego L, , 2007. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis. Vet Immunol Immunopathol 116: 190198.[Crossref]
  7. Ciaramella P, Oliva G, Luna RD, Gradoni L, Ambrosio R, Cortese L, Scalone A, Persechino A, , 1997. A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum . Vet Rec 141: 539543.[Crossref]
  8. Solano-Gallego L, Riera C, Roura X, Iniesta L, Gallego M, Valladares JE, Fisa R, Castillejo S, Alberola J, Ferrer L, Arboix M, Portus M, , 2001. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Vet Parasitol 96: 265276.[Crossref]
  9. Borja-Cabrera GP, Correia Pontes NN, da Silva VO, Paraguai de Souza E, Santos WR, Gomes EM, Luz KG, Palatnik M, Palatnik de Sousa CB, , 2002. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN). Vaccine 20: 32773284.[Crossref]
  10. Fernandes AP, Costa MM, Coelho EA, Michalick MS, de Freitas E, Melo MN, Luiz Tafuri W, Resende Dde M, Hermont V, Abrantes Cde F, Gazzinelli RT, , 2008. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 26: 58885895.[Crossref]
  11. Miro G, Cardoso L, Pennisi MG, Oliva G, Baneth G, , 2008. Canine leishmaniosis–new concepts and insights on an expanding zoonosis: part two. Trends Parasitol 24: 371377.[Crossref]
  12. Denerolle P, Bourdoiseau G, , 1999. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases). J Vet Intern Med 13: 413415.[Crossref]
  13. Rhalem A, Sahibi H, Lasri S, Jaffe CL, , 1999. Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment. Vet Immunol Immunopathol 71: 6976.[Crossref]
  14. Moreno J, Nieto J, Chamizo C, Gonzalez F, Blanco F, Barker DC, Alva J, , 1999. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Vet Immunol Immunopathol 71: 181195.[Crossref]
  15. Riera C, Valladares JE, Gallego M, Aisa MJ, Castillejo S, Fisa R, Ribas N, Carrio J, Alberola J, Arboix M, , 1999. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Vet Parasitol 84: 3347.[Crossref]
  16. Pasa S, Toz SO, Voyvoda H, Ozbel Y, , 2005. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate. Vet Parasitol 128: 243249.[Crossref]
  17. Manna L, Reale S, Vitale F, Picillo E, Pavone LM, Gravino AE, , 2008. Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol. Vet J 177: 279282.[Crossref]
  18. Noli C, Auxilia ST, , 2005. Treatment of canine Old World visceral leishmaniasis: a systematic review. Vet Dermatol 16: 213232.[Crossref]
  19. Gramiccia M, Gradoni L, Orsini S, , 1992. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann Trop Med Parasitol 86: 613620.[Crossref]
  20. Carrio J, Portus M, , 2002. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate. BMC Pharmacol 2: 11.[Crossref]
  21. Koutinas AF, Saridomichelakis MN, Mylonakis ME, Leontides L, Polizopoulou Z, Billinis C, Argyriadis D, Diakou N, Papadopoulos O, , 2001. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis. Vet Parasitol 98: 247261.[Crossref]
  22. Rodriguez A, Solano-Gallego L, Ojeda A, Quintana J, Riera C, Gallego M, Portus M, Alberola J, , 2006. Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment. J Vet Intern Med 20: 495498.[Crossref]
  23. Todoli F, Perez-Filgueira M, Galindo I, Gomez-Sebastian S, Escribano JM, Rodriguez-Cortes A, Alberola J, , 2009. Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs. Vet Parasitol 164: 154161.[Crossref]
  24. Berberich C, Requena JM, Alonso C, , 1997. Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein. Exp Parasitol 85: 105108.[Crossref]
  25. Passos S, Carvalho LP, Orge G, Jeronimo SM, Bezerra G, Soto M, Alonso C, Carvalho EM, , 2005. Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 12: 11641167.
  26. Santarem N, Tomas A, Ouaissi A, Tavares J, Ferreira N, Manso A, Campino L, Correia JM, Cordeiro-da-Silva A, , 2005. Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunol Lett 101: 1823.[Crossref]
  27. Manna L, Vitale F, Reale S, Caracappa S, Pavone LM, Morte RD, Cringoli G, Staiano N, Gravino AE, , 2004. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis. Vet Parasitol 125: 251262.[Crossref]
  28. Ikeda-Garcia FA, Lopes RS, Marques FJ, de Lima VM, Morinishi CK, Bonello FL, Zanette MF, Perri SH, Feitosa MM, , 2007. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Vet Parasitol 143: 254259.[Crossref]
  29. Ribeiro RR, Moura EP, Pimentel VM, Sampaio WM, Silva SM, Schettini DA, Alves CF, Melo FA, Tafuri WL, Demicheli C, Melo MN, Frezard F, Michalick MS, , 2008. Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate. Antimicrob Agents Chemother 52: 25642572.[Crossref]
  30. Solano-Gallego L, Koutinas A, Miro G, Cardoso L, Pennisi MG, Ferrer L, Bourdeau P, Oliva G, Baneth G, , 2009. Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. Vet Parasitol 165: 118.[Crossref]
  31. Fernandez-Perez FJ, Mendez S, de la Fuente C, Cuquerella M, Gomez MT, Alunda JM, , 1999. Value of Western blotting in the clinical follow-up of canine leishmaniasis. J Vet Diagn Invest 11: 170173.[Crossref]
  32. Talmi-Frank D, Strauss-Ayali D, Jaffe CL, Baneth G, , 2006. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis. Clin Vaccine Immunol 13: 271276.[Crossref]
  33. Carrera L, Fermin ML, Tesouro M, Garcia P, Rollan E, Gonzalez JL, Mendez S, Cuquerella M, Alunda JM, , 1996. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. Exp Parasitol 82: 139146.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0147
Loading
/content/journals/10.4269/ajtmh.2010.09-0147
Loading

Data & Media loading...

  • Received : 18 Mar 2009
  • Accepted : 30 Dec 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error